Nine Point Two Capital LLC Neogenomics Inc Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Nine Point Two Capital LLC holds 15,683 shares of NEO stock, worth $156,045. This represents 0.1% of its overall portfolio holdings.
Number of Shares
15,683
Previous 15,683
-0.0%
Holding current value
$156,045
Previous $192,000
31.77%
% of portfolio
0.1%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$196 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$142 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$65 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$61.3 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$61.3 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.25B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...